AVXL
ANAVEX LIFE SCIENCES CORP.
Nasdaq Biological Products, (No Diagnostic Substances) Large accelerated filer

Key Financials

Net Income
$-46377000
↓ 7.8%
Operating Income
$-51408000
↑ 2.8%
EPS (Diluted)
$-0.54
↓ 3.8%
Total Assets
$103.8M
↓ 23.4%
Total Liabilities
$8.9M
↓ 41.5%
Shareholders' Equity
$94.9M
↓ 21.1%
Cash & Equivalents
$102.6M
↓ 22.4%
Long-term Debt
$332.00
0.0%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G/A 3/26/2026 View on SEC
8-K 3/25/2026 View on SEC
8-K 2/25/2026 View on SEC
10-Q 2/9/2026 View on SEC
8-K 2/9/2026 View on SEC
4 1/9/2026 View on SEC
4 1/9/2026 View on SEC
10-K 11/25/2025 View on SEC
8-K 11/25/2025 View on SEC
8-K 11/14/2025 View on SEC

Company Information

Field Value
Ticker AVXL
Company Name ANAVEX LIFE SCIENCES CORP.
CIK 1314052
Sector Biological Products, (No Diagnostic Substances)
Industry Large accelerated filer
Exchange Nasdaq
SIC Code 2836
SIC Description Biological Products, (No Diagnostic Substances)
Entity Type operating
Fiscal Year End 0930
Phone 844-689-3939